These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2557496)

  • 1. Smoking, estrogen, and prevention of heart disease in women.
    Stampfer MJ
    Mayo Clin Proc; 1989 Dec; 64(12):1553-7. PubMed ID: 2557496
    [No Abstract]   [Full Text] [Related]  

  • 2. The Rochester Coronary Heart Disease Project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40- to 59-year-old women, 1960 through 1982.
    Beard CM; Kottke TE; Annegers JF; Ballard DJ
    Mayo Clin Proc; 1989 Dec; 64(12):1471-80. PubMed ID: 2557493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and heart disease prevention: experimentation trumps observation.
    Petitti DB
    JAMA; 1998 Aug; 280(7):650-2. PubMed ID: 9718060
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone replacement therapy should not be used as secondary prevention of coronary heart disease.
    Barbour MM
    Pharmacotherapy; 2000 Sep; 20(9):1021-7. PubMed ID: 10999492
    [No Abstract]   [Full Text] [Related]  

  • 5. HRT and the young at heart.
    Mendelsohn ME; Karas RH
    N Engl J Med; 2007 Jun; 356(25):2639-41. PubMed ID: 17582075
    [No Abstract]   [Full Text] [Related]  

  • 6. Protecting older women from their growing risk of cardiac disease.
    Nachtigall LE; Nachtigall LB
    Geriatrics; 1990 May; 45(5):24-9, 33-4. PubMed ID: 2332176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy to prevent coronary events.
    Richard D; Newton WP
    J Fam Pract; 1998 Nov; 47(5):333-4. PubMed ID: 9834761
    [No Abstract]   [Full Text] [Related]  

  • 8. [[Estrogen therapy after menopause and cardiovascular protection: discordance between epidemiologic observations and the results of therapeutic trials] ].
    Scheen AJ
    Rev Med Liege; 2000 Sep; 55(9):886-8. PubMed ID: 11105606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The WHI estrogen-alone trial--do things look any better?
    Hulley SB; Grady D
    JAMA; 2004 Apr; 291(14):1769-71. PubMed ID: 15082705
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
    Herrington DM; Reboussin DM; Brosnihan KB; Sharp PC; Shumaker SA; Snyder TE; Furberg CD; Kowalchuk GJ; Stuckey TD; Rogers WJ; Givens DH; Waters D
    N Engl J Med; 2000 Aug; 343(8):522-9. PubMed ID: 10954759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coronary disease in women].
    García-Palmieri MR; Perea-López RM
    P R Health Sci J; 1996 Dec; 15(4):283-8. PubMed ID: 9190622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen therapy and coronary-artery calcification.
    Manson JE; Allison MA; Rossouw JE; Carr JJ; Langer RD; Hsia J; Kuller LH; Cochrane BB; Hunt JR; Ludlam SE; Pettinger MB; Gass M; Margolis KL; Nathan L; Ockene JK; Prentice RL; Robbins J; Stefanick ML;
    N Engl J Med; 2007 Jun; 356(25):2591-602. PubMed ID: 17582069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention of coronary heart disease: a critique.
    Borhani NO
    Am J Cardiol; 1977 Aug; 40(2):251-9. PubMed ID: 195453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of estrogen-progestins in secondary prevention].
    Modena MG; Origliani G; Rossi R
    Ital Heart J Suppl; 2000 Mar; 1(3):435-6. PubMed ID: 10815281
    [No Abstract]   [Full Text] [Related]  

  • 16. The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).
    Simon JA; Lin F; Vittinghoff E; Bittner V;
    Ann Epidemiol; 2006 Feb; 16(2):138-45. PubMed ID: 16039873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summaries for patients: The effect of estrogen plus progestin on coronary heart disease.
    Ann Intern Med; 2010 Feb; 152(4):I-40. PubMed ID: 20157120
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronary heart disease in women. The high prevalance of coronary risk factors and the importance of prevention.
    Wenger NK
    J Med Assoc Ga; 1995 Sep; 84(7):323-8. PubMed ID: 7561540
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estrogen replacement therapy and coronary disease].
    Lengfelder W
    Dtsch Med Wochenschr; 2000 Sep; 125(37):1090-4. PubMed ID: 11036488
    [No Abstract]   [Full Text] [Related]  

  • 20. [Are hormone substitution and vitamins dangerous for elderly women with heart diseases?].
    Schenck-Gustafsson K
    Lakartidningen; 2003 May; 100(20):1784-6. PubMed ID: 12806858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.